Options Trading News

July 31, 2013  Wed 2:14 AM CT

A long-term trade sees little upside for Pfizer.

optionMONSTER systems detected the sale of 23,329 January 2015 30 calls in one print for the bid price of $2.18. The volume was twice the previous open interest, clearly showing that this is a new position.

The options were likely sold against long shares in a covered-call position, given how close the strike is to the stock price, suggesting that the investor anticipates range-bound action. But the trader may actually hope to be forced to sell shares with PFE above $30, allowing him or her to get paid for exiting a long position. (See our Education section)

PFE rose 0.44 percent to $29.67 yesterday. The pharmaceutical giant was off its highs from the morning but still at its best levels since the end of April.

Total option volume in Pfizer topped 287,000 contracts yesterday, 10 times its daily average for the last month.
Share this article with your friends

Related Stories


How fast money flowed in Pfizer

September 25, 2015

The pharmaceutical company been has been range-bound since last month's big market drop but is one of the stronger drug makers overall.

Invest Like a Monster - San Antonio: October 9-10

Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »